These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27840279)

  • 1. Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer.
    Shi L; Zheng M; Hou J; Zhu B; Wang X
    Semin Cancer Biol; 2017 Feb; 42():4-12. PubMed ID: 27840279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.
    Feinberg AP; Koldobskiy MA; Göndör A
    Nat Rev Genet; 2016 May; 17(5):284-99. PubMed ID: 26972587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetics in lung cancer diagnosis and therapy.
    Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
    Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.
    Sheervalilou R; Shirvaliloo S; Fekri Aval S; Khamaneh AM; Sharifi A; Ansarin K; Zarghami N
    Tumour Biol; 2017 May; 39(5):1010428317695032. PubMed ID: 28468581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of epigenetics in lung cancer heterogeneity and clinical implication.
    Dong N; Shi L; Wang DC; Chen C; Wang X
    Semin Cell Dev Biol; 2017 Apr; 64():18-25. PubMed ID: 27575638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.
    Suzuki H; Maruyama R; Yamamoto E; Niinuma T; Kai M
    Adv Exp Med Biol; 2016; 927():109-35. PubMed ID: 27376733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
    Ramakrishnan S; Pili R
    Cancer J; 2013; 19(4):333-40. PubMed ID: 23867515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Modifications and Modulators in Prostate Cancer.
    Cimadamore A; Gasparrini S; Scarpelli M; Doria A; Mazzucchelli R; Massari F; Cheng L; Lopez-Beltran A; Montironi R
    Crit Rev Oncog; 2017; 22(5-6):439-450. PubMed ID: 29604923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation and cancer (review).
    Chen QW; Zhu XY; Li YY; Meng ZQ
    Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Determinants of Epigenetic Patterns: Providing Insight into Disease.
    Cazaly E; Charlesworth J; Dickinson JL; Holloway AF
    Mol Med; 2015 Mar; 21(1):400-9. PubMed ID: 25822796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.
    Bhalla KN
    J Clin Oncol; 2005 Jun; 23(17):3971-93. PubMed ID: 15897549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of epigenetic alterations in lung carcinogenesis.
    Brzeziańska E; Dutkowska A; Antczak A
    Mol Biol Rep; 2013 Jan; 40(1):309-25. PubMed ID: 23086271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and development of DNA methylation-based biomarkers for lung cancer.
    Walter K; Holcomb T; Januario T; Yauch RL; Du P; Bourgon R; Seshagiri S; Amler LC; Hampton GM; S Shames D
    Epigenomics; 2014 Feb; 6(1):59-72. PubMed ID: 24579947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.
    Lee JY; Kong G
    Cell Mol Life Sci; 2016 Dec; 73(24):4643-4660. PubMed ID: 27460000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic targets in human neoplasms.
    Fandy TE; Gore SD
    Epigenomics; 2010 Apr; 2(2):221-32. PubMed ID: 22121872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Roles of DNA Methylation in the Stages of Cancer.
    McMahon KW; Karunasena E; Ahuja N
    Cancer J; 2017; 23(5):257-261. PubMed ID: 28926425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of miR-129-2 and its effects on the proliferation and invasion in lung cancer cells.
    Xiao Y; Li X; Wang H; Wen R; He J; Tang J
    J Cell Mol Med; 2015 Sep; 19(9):2172-80. PubMed ID: 26081366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress on epigenetics of lung cancer].
    Wang Y; Jin Y
    Wei Sheng Yan Jiu; 2007 Jan; 36(1):109-11. PubMed ID: 17424862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer epigenetics: From knowledge to applications.
    Duruisseaux M; Esteller M
    Semin Cancer Biol; 2018 Aug; 51():116-128. PubMed ID: 28919484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.